Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.
Saved in:
| Title: | Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial. |
|---|---|
| Authors: | Nyombayire J; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Ingabire R; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Mazzei A; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Sharkey T; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Umuhoza C; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Mukamuyango J; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda., Allen S; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Tichacek A; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Parker R; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Wall KM; Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, Emory University, Atlanta, GA, USA. kmwall@emory.edu., Katwere M; Johnson & Johnson, Leiden, the Netherlands., Keshinro B; Johnson & Johnson, Leiden, the Netherlands., Gaddah A; Johnson & Johnson, Beerse, Belgium., Wang Y; IQVIA Research & Development Solutions, Durham, NC, USA., Forcheh CA; Johnson & Johnson, Toronto, Ontario, Canada., McLean C; Johnson & Johnson, Leiden, the Netherlands., Oriol-Mathieu V; Johnson & Johnson, Leiden, the Netherlands., Luhn K; Johnson & Johnson, Leiden, the Netherlands., Robinson C; Johnson & Johnson, Leiden, the Netherlands., Karita E; Rwanda Zambia Health Research Group, Center for Family Health Research/Project San Francisco, Kigali, Rwanda. |
| Source: | Nature medicine [Nat Med] 2025 Nov; Vol. 31 (11), pp. 3899-3906. Date of Electronic Publication: 2025 Sep 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
